GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Amniotics AB (OSTO:AMNI) » Definitions » Tax Provision

Amniotics AB (OSTO:AMNI) Tax Provision : kr0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Amniotics AB Tax Provision?

Amniotics AB's tax provision for the three months ended in Dec. 2023 was kr0.00 Mil. Its tax provision for the trailing twelve months (TTM) ended in Dec. 2023 was kr0.00 Mil.


Amniotics AB Tax Provision Historical Data

The historical data trend for Amniotics AB's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amniotics AB Tax Provision Chart

Amniotics AB Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Tax Provision
- - - - -

Amniotics AB Quarterly Data
Dec19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Sep23 Dec23
Tax Provision Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Amniotics AB Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Amniotics AB (OSTO:AMNI) Business Description

Traded in Other Exchanges
Address
Scheelevagen 2, Lund, SWE, 223 63
Amniotics AB is a biopharma company focusing on mesenchymal stem cells from amniotic fluid. It provides a novel platform for the production of medically superior mesenchymal stem cells including ethical and medically sound bio-banking opportunities for the newborn.

Amniotics AB (OSTO:AMNI) Headlines

From GuruFocus

American Noble Gas Announces Ticker Symbol Change

By Stock market mentor Stock market mentor 01-23-2023